Cizzle Biotechnology Holdings (CIZ) RNS Announcements

Add to Alert list
Date Time Source Announcement
14 May 2021 07:00 AM
RNS
First Day of Dealings

Cizzle Biotechnology Holdings engages in developing a blood test for the early detection of various forms of lung cancer. It develops CIZ1B protein gene and its potential as a diagnostic biomarker for detection and management of lung cancer.

CIZ share price listed at 9p in 2021.

UK 100

Latest directors dealings